Omeros Corporation
meros Corporation was founded in 1994 and is based in Seattle, Washington. Omeros Corporation is a clinical-stage biopharmaceutical company engaged in discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. The Company’s clinically advanced product candidates are derived from its PharmacoSurgerytm platform designed to improve the clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Its PharmacoSurgery platform is based on low-dose combinations of therapeutic agents delivered directly to the surgical site throughout the duration of the procedure to preemptively inhibit inflammation and other problems caused by surgical trauma and to provide clinical benefits both during and after surgery.
Contact Details
Office Address
Omeros Corporation
1420 Fifth Avenue, Suite 2600
Seattle, WA, USA 98101
Phone: (206) 676-5000
Fax: (206) 676-5005
Executives
Co-Founder, Chairman & Chief Exec. Officer
Dr. Gregory A. Demopulos
VP of Patent, Sec. and Gen. Counsel
Ms. Marcia S. Kelbon Esq.